Financial disclosures of interactions with healthcare professionals/organizations
Working with healthcare professionals
The relationships between industry and healthcare professionals, or HCPs, and healthcare organizations, or HCOs, provide invaluable benefits to the advancement of modern medicine. As global healthcare has evolved, public interest in the nature of these relationships has grown along with public interest in understanding whether any potential conflicts of interest may arise as well.
Bristol Myers Squibb believes in fostering an open environment to help build a foundation of trust, credibility, and respect among our colleagues, healthcare providers, patients, stockholders, and the public. Bristol Myers Squibb further believes that interactions with individuals and institutions in the healthcare delivery system should take place in an open, honest, and ethical manner. These interactions should be based on the pursuit of objective science and the communication of scientifically accurate information, and relate to matters that are important to healthcare providers and patients.
Our company is committed to complying with financial disclosure laws and codes as an extension of our own efforts to increase public awareness of the positive collaboration between industry and HCPs/HCOs.
Global disclosures of payments and transfers of value
Bristol Myers Squibb publishes payments and other transfers of value made to Healthcare Professionals and Organizations in accordance with local laws, industry codes and regulations.
United States
Under the Physician Payments Sunshine Act (PPSA), Bristol Myers Squibb is required to disclose each year the financial relationship between the company and HCPs/HCOs. The data is submitted to the Open Payments system, a platform administered by the Centers for Medicare and Medicaid Services (CMS). The data collected by CMS is available to the public through the same Open Payments platfom.
Europe
Across Europe, Bristol Myers Squibb discloses annually payments and other transfers of value for 30+ countries in line with the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code The EFPIA Code and related national legislation and codes. The signed EFPIA Disclosure Code Self-Certification Letters confirm our commitment to the principles of the EFPIA Code of Practice:
Bristol Myers Squibb’s financial and non-financial support for Patient Organizations in our specified disease areas is disclosed separately, and can be accessed here Support for European patient organizations.
Rest of World
Outside of Europe and the US, Bristol Myers Squibb continues to adapt its transparency reporting processes to meet the requirements of government and industry associations. We disclose payments and transfers of value to HCPs and HCOs in line with these local regulations, and wherever mandated these disclosures are publicly available. Examples of these payments and other transfers of value include the provision of professional medical expertise during advisory boards , services such as speaking at medical & scientific events, research and educational grants.
Find out more about interactions with HCPs and HCOs around the globe.
Select from the countries below for more information.